Format

Send to

Choose Destination
See comment in PubMed Commons below
Neuroradiology. 2001 May;43(5):345-52.

Proton magnetic resonance spectroscopy in brain tumours: clinical applications.

Author information

1
Department of Diagnostic Radiology, University Hospital, Lund, Sweden. isabella.burtscher@drad.lu.se

Abstract

Parallel to the rapid development of clinical MRI, MR spectroscopy (MRS) has, after starting as an analytical tool used in chemistry and physics, evolved to a noninvasive clinical examination. Most common neuroradiological diagnostic indications for MRS are functional inborn errors, neonatal hypoxia, ischaemia, metabolic diseases, white matter and degenerative diseases, epilepsy, inflammation, infections and intracranial neoplasm. Compared to CT and MRI, well-established morphological diagnostic tools, MRS provides information on the metabolic state of brain tissue. We review the clinical impact of MRS in diagnosis of tumours and their differentiation from non-neoplastic lesions.

PMID:
11396737
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center